PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
The Korean Journal of Urological Oncology10.22465/kjuo.2020.18.2.73202018273-77Therapeutic Options in High-Risk Nonmuscle Invasive Bladder Cancer During the Shortage of Bacillus Calmette-GuérinJeongwan Yoo, Yeon Joo Kim, Bum Sik Tae, Jae Young Parkhttp://kjuo.or.kr/upload/pdf/kjuo-18-2-73.pdf, http://kjuo.or.kr/journal/view.php?doi=10.22465/kjuo.2020.18.2.73, http://kjuo.or.kr/upload/pdf/kjuo-18-2-73.pdf
Cancer10.1002/cncr.2362720081134710-716Maintenance bacillus Calmette-Guérin in high-risk nonmuscle-invasive bladder cancerMarc Decobert, Hélène LaRue, François Harel, François Meyer, Yves Fradet, Louis Lacombehttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fcncr.23627, https://onlinelibrary.wiley.com/doi/full/10.1002/cncr.23627
Urology10.1016/j.urology.2018.07.0552019124120-126Utilization of Bacillus Calmette-Guerin for Nonmuscle Invasive Bladder Cancer in an Era of Bacillus Calmette-Guerin Supply ShortagesAbhinav Khanna, Nitin Yerram, Hui Zhu, Simon Kim, Robert Abouassalyhttps://api.elsevier.com/content/article/PII:S0090429518309518?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0090429518309518?httpAccept=text/plain
European Urology10.1016/j.eururo.2014.11.0312015673359-360Therapeutic Options in High-risk Non–muscle-invasive Bladder Cancer During the Current Worldwide Shortage of Bacille Calmette-GuérinA. Hugh Mostafid, Joan Palou Redorta, Richard Sylvester, J. Alfred Witjeshttps://api.elsevier.com/content/article/PII:S0302283814012147?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0302283814012147?httpAccept=text/plain
Urological Science10.1016/j.urols.2015.04.0052015262101-102Editorial comment on “Maintenance bacillus Calmette-Guérin therapy for nonmuscle-invasive bladder cancer: A need for more randomized trials”Shu-Pin Huanghttp://api.elsevier.com/content/article/PII:S1879522615000652?httpAccept=text/xml, http://api.elsevier.com/content/article/PII:S1879522615000652?httpAccept=text/plain
European Urology10.1016/j.eururo.2014.12.0502015674815Re: The Effect of Restaging Transurethral Resection on Recurrence and Progression Rates in Patients with Nonmuscle Invasive Bladder Cancer Treated with Intravesical Bacillus Calmette-GuerinMarko Babjukhttps://api.elsevier.com/content/article/PII:S0302283814014067?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0302283814014067?httpAccept=text/plain
Journal of Urology10.1016/j.juro.2013.06.03020131903832-833The Challenge of Bacillus Calmette-Guérin Failure in Nonmuscle Invasive Bladder Cancer—What is the Next Step in Management?Yair Lotanhttps://api.elsevier.com/content/article/PII:S0022534713046272?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0022534713046272?httpAccept=text/plain
BJU International10.1111/j.1464-410x.2008.08094.x20091036726-729Therapeutic options in the management of intermediate-risk nonmuscle-invasive bladder cancerAndras Horvath, Hugh Mostafidhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1464-410X.2008.08094.x
Urologia Internationalis10.1159/000440701201596146-50The Moreau Strain of Bacillus Calmette-Guerin (BCG) for High-Risk Non-Muscle Invasive Bladder Cancer: An Alternative during Worldwide BCG Shortage?Sebastian L. Hofbauer, Shahrokh F. Shariat, Daher C. Chade, Alvaro S. Sarkis, Leopoldo A. Ribeiro-Filho, Willian C. Nahas, Tobias Klattehttps://www.karger.com/Article/Pdf/440701, http://www.karger.com/Article/Pdf/440701
Surgical Oncology10.1016/s0960-7404(02)00008-72002111-277-83BCG (Bacillus of Calmette Guerin) therapy of high-risk superficial bladder cancerPierFrancesco Bassihttps://api.elsevier.com/content/article/PII:S0960740402000087?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0960740402000087?httpAccept=text/plain